Understanding beta-lactam antibiotic targets to improve melioidosis treatment

Project Code

IIAR27Br Spencer

Project Type

Wet lab

Research Theme

Infection, Immunity, and Antimicrobial Resistance

Project Summary Download

Summary

Melioidosis, caused by the bacterium Burkholderia pseudomallei, is a severe, frequently fatal, tropical disease. Beta-lactam antibiotics are cornerstones of melioidosis treatment, but are variably effective in resolving B. pseudomallei infections. New, more effective treatments are needed for this under-studied disease. Beta-lactams target transpeptidase enzymes, primarily penicillin-binding proteins (PBPs), that catalyse cross-linking of the bacterial cell wall; B. pseudomallei transpeptidases are however little studied. This project combines structural, biochemical, computational and microbiological approaches to investigate B. pseudomallei transpeptidases, aiming to establish their reactivity towards different beta-lactams in vitro, and subsequently whether combining beta-lactams represents a route to more effective melioidosis treatments.

Can the project be completed part time?

Yes

Lead Supervisor

Professor James Spencer

Lead Supervisor Email

Jim.Spencer@bristol.ac.uk

University Affiliation

University of Bristol

Back to top ↑